Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olaussen

Showing results (151-160 of 183) with videos related to

Pageof 19
Sort By:
Lung Cancer (Amsterdam, Netherlands)|February 16, 2013
PARP1 impact on DNA repair of platinum adducts: preclinical and clinical read-outsKen A Olaussen, Julien Adam, Elsa Vanhecke, et al.
Clinical Lung Cancer|June 19, 2013
19q13-ERCC1 gene copy number increase in non--small-cell lung cancerElsa Vanhecke, Alexander Valent, Ximing Tang, et al.
BMC Palliative Care|March 29, 2023
Simulation-based learning in palliative care in postgraduate nursing education: a scoping reviewKaroline Skedsmo, Andréa Aparecida Gonçalves Nes, Hege Vistven Stenseth, et al.
Leukemia|July 28, 2023
WT1 and PRAME RNA-loaded dendritic cell vaccine as maintenance therapy in de novo AML after intensive induction chemotherapyYngvar Fløisand, Mats Remberger, Iris Bigalke, et al.
Clinical Lung Cancer|July 12, 2023
Association of Molecular Profiles and Mutational Status With Distinct Histological Lung Adenocarcinoma Subtypes. An Analysis of the LACE-Bio DataPrashanth Ashok Kumar, Maryam Karimi, Alina Basnet, et al.
The New England Journal of Medicine|September 8, 2006
DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapyKen A Olaussen, Ariane Dunant, Pierre Fouret, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2011
Molecular Characteristics of ERCC1-Negative versus ERCC1-Positive Tumors in Resected NSCLCLuc Friboulet, Daniel Barrios-Gonzales, Frédéric Commo, et al.
European Journal of Cancer (Oxford, England : 1990)|May 11, 2020
Molecular mechanisms of resistance to BRAF and MEK inhibitors in BRAF<sup>V600E</sup> non-small cell lung cancerFrancesco Facchinetti, Ludovic Lacroix, Laura Mezquita, et al.
BMC Cancer|July 17, 2016
Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected non-small cell lung cancerMathieu Rouanne, Julien Adam, Aïcha Goubar, et al.
Oncogene|April 29, 2009
Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndromeS Boehrer, L Adès, N Tajeddine, et al.
Pageof 19

Showing results (151-160 of 183) with videos related to

Sort By:
Pageof 19
Lung Cancer (Amsterdam, Netherlands)|February 16, 2013
PARP1 impact on DNA repair of platinum adducts: preclinical and clinical read-outsKen A Olaussen, Julien Adam, Elsa Vanhecke, et al.
Clinical Lung Cancer|June 19, 2013
19q13-ERCC1 gene copy number increase in non--small-cell lung cancerElsa Vanhecke, Alexander Valent, Ximing Tang, et al.
BMC Palliative Care|March 29, 2023
Simulation-based learning in palliative care in postgraduate nursing education: a scoping reviewKaroline Skedsmo, Andréa Aparecida Gonçalves Nes, Hege Vistven Stenseth, et al.
Leukemia|July 28, 2023
WT1 and PRAME RNA-loaded dendritic cell vaccine as maintenance therapy in de novo AML after intensive induction chemotherapyYngvar Fløisand, Mats Remberger, Iris Bigalke, et al.
Clinical Lung Cancer|July 12, 2023
Association of Molecular Profiles and Mutational Status With Distinct Histological Lung Adenocarcinoma Subtypes. An Analysis of the LACE-Bio DataPrashanth Ashok Kumar, Maryam Karimi, Alina Basnet, et al.
The New England Journal of Medicine|September 8, 2006
DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapyKen A Olaussen, Ariane Dunant, Pierre Fouret, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2011
Molecular Characteristics of ERCC1-Negative versus ERCC1-Positive Tumors in Resected NSCLCLuc Friboulet, Daniel Barrios-Gonzales, Frédéric Commo, et al.
European Journal of Cancer (Oxford, England : 1990)|May 11, 2020
Molecular mechanisms of resistance to BRAF and MEK inhibitors in BRAF<sup>V600E</sup> non-small cell lung cancerFrancesco Facchinetti, Ludovic Lacroix, Laura Mezquita, et al.
BMC Cancer|July 17, 2016
Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected non-small cell lung cancerMathieu Rouanne, Julien Adam, Aïcha Goubar, et al.
Oncogene|April 29, 2009
Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndromeS Boehrer, L Adès, N Tajeddine, et al.
Pageof 19